These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1224473)

  • 1. [Results of combined anti-recurrence treatment of herpetic eye disease].
    Chaglakov IuA
    Vestn Oftalmol; 1975; (6):28-32. PubMed ID: 1224473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Herpetic pathology and current methods of treating herpetic lesions].
    Zhdanov VM; Barinskiĭ IF; Galegov GA; Ershov FI
    Sov Med; 1983; (10):65-9. PubMed ID: 6362030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of herpetic keratitis with interferon and its inducer in an experiment].
    Bostandzhian MG; Nurmamedov NN; Annanepesov IaKh; Nazarov RO
    Vestn Oftalmol; 1987; 103(3):57-9. PubMed ID: 2442876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nonspecific immunotherapy of ophthalmic herpes].
    Kasparov AA; Voĭtsekhovskaia AA; Fadeeva LL; Ul'ianopva TIu; Khavinson VKh
    Vestn Oftalmol; 1986; 102(3):44-7. PubMed ID: 2425474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complex treatment and prevention of recurrence in patients with ocular herpes].
    Gorgiladze TU; Gaĭdamaka TB
    Oftalmol Zh; 1987; (3):157-61. PubMed ID: 3037460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Herpes vaccination in the treatment of dendritic keratitis].
    François J; van den Neste C
    Duodecim; 1974; 90(1):18-21. PubMed ID: 4368148
    [No Abstract]   [Full Text] [Related]  

  • 7. [The combined treatment of recurrent forms of herpetic keratitis].
    Vin'kova GA
    Oftalmol Zh; 1989; (4):221-4. PubMed ID: 2797696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new interferon inducer Aktipol in the treatment of herpetic keratitis].
    Akberova SI; Musaev Galbinur PI
    Vestn Oftalmol; 2000; 116(2):16-8. PubMed ID: 11055216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with the combined treatment of recurrent herpes using larifan and a herpetic vaccine].
    Potekaev NS; Nosik NN; Samgin MA; Kudratullaev KN; Lavrukhina LA
    Klin Med (Mosk); 1992 Jan; 70(1):67-70. PubMed ID: 1318984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Main trends in the treatment of ophthalmic herpes].
    Kasparov AA
    Oftalmol Zh; 1981; 36(3):129-33. PubMed ID: 7279365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the diagnostic and therapeutic use of herpetic polyvaccine].
    Kasparov AA; Maevskaia TM
    Oftalmol Zh; 1972; 27(2):119-24. PubMed ID: 4337641
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects of prevention of recurrent herpetic eye disease.
    Jones BR; Coster DJ; Falcon MG
    Trans Ophthalmol Soc U K (1962); 1977 Jul; 97(2):350-5. PubMed ID: 273346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of interferon inductors in current antiviral therapy for herpetic eye disease].
    Kasparov AA
    Vestn Oftalmol; 1972; 2():63-7. PubMed ID: 4664147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoglobulins in patients with recurrent ocular herpes and after anti-recurrence vaccination].
    Zaĭtseva NS; Cheglakov IuA; Murav'eva TV; Kasparov AA; Maevskaia TM
    Vestn Oftalmol; 1975; (5):67-72. PubMed ID: 190752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Local interferon formation and prophylactic instillation of interferon inducers].
    Cheglakov IuA; Konosh OV; Kasparov AA
    Vestn Oftalmol; 1976; (2):45-7. PubMed ID: 1014185
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of an immunoglobulin in the comprehensive treatment of ophthalmic herpes].
    Butiukova VA; Soldatenkova NA; Ostrovskaia OV; Nefedova OA; Vlasova MA
    Oftalmol Zh; 1990; (3):162-3. PubMed ID: 2255481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microdiathermocoagulation in the treatment of herpetic keratitis].
    Kasparov AA; Oganesiants VA; Riabokon' BV; Gorbovitskaia GE
    Vestn Oftalmol; 1990; 106(1):37-41. PubMed ID: 2378035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology and clinical problems of herpetic eye diseases (retrospective analysis)].
    Pietruschka G
    Z Arztl Fortbild (Jena); 1982 Nov; 76(22):966-9. PubMed ID: 6984990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the therapeutic effect of penetrating keratoplasty in herpes simplex keratitis].
    Xie LX
    Zhonghua Yan Ke Za Zhi; 1987 Mar; 23(2):65-8. PubMed ID: 3113872
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of human herpetic keratitis.
    de la Pena NC; Diaz A; Damel A; Bal E; Puricelli L; Ejden J; de Lustig ES
    Biomedicine; 1978 May; 28(2):104-8. PubMed ID: 352419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.